The Angioplasty Balloons Market is expanding as healthcare providers increasingly adopt minimally invasive approaches for treating vascular conditions. Angioplasty balloons are used to widen narrowed or blocked blood vessels and remain an important component of interventional cardiovascular procedures.

Market Research Future estimates that the global market was valued at about USD 3.38 billion in 2024 and is projected to reach USD 5.1 billion by 2035, representing a CAGR of 3.81% from 2025 to 2035.

Technological development is an important factor shaping the industry. Manufacturers are working on improved balloon designs, delivery systems, drug-eluting technologies, and advanced materials to support more precise procedures. Drug-eluting balloons have a significant position in the market, while scoring balloons are also gaining attention because of their specialized design.

The growing burden of cardiovascular diseases is another factor supporting demand. Increased healthcare investment and greater awareness of cardiovascular treatment options are also encouraging the adoption of angioplasty procedures.

Hospitals currently account for a substantial share of end-user demand, while ambulatory surgical centers are developing as an increasingly important setting for minimally invasive procedures.

With continued innovation and investment in cardiovascular healthcare infrastructure, the angioplasty balloons industry is expected to experience steady development through 2035.

Dive into related studies for a broader industry perspective:

Acute Hospital Care Market Forecast

Medical Equipment Rental Market Outlook

Animal Wound Care Market Analysis

Connected Healthcare Devices Market Distribution

Marine Collagen Market Size